You are welcome to attend the Seminar. Please find the details below:

Date: 22 Aug 2024 (Thu)
Time: 3:00pm - 5:00pm (Registration starts at 2:30pm)
Venue: Lecture Theatre 2, 1/F, HKUMed Academic Building, 3 Sassoon Road, Pokfulam, Hong Kong
Mode: Face to face
Fee: Free of Charge
Registration: HERE
Enquires: Tel: 81000538；Email: scmevent@hku.hk

Speaker:
Professor Zhiqiang Meng
Professor/Chief Physician
Director, Department of Integrative Oncology
Director, Minimally Invasive Therapy Center
Fudan University Shanghai Cancer Center

Abstract:

This presentation explores advancements in integrative oncology for liver and pancreatic cancer, merging traditional Chinese medicine with modern practices. Highlights include minimally invasive therapies, clinical application of Huachansu (bufalin) for liver cancer. For pancreatic cancer, it covers studies on "Zheng" syndrome—from clinical observation to molecular differentiation—and clinical trials targeting damp-heat Zheng syndrome with specific TCM formulas. The discussion also delves into translational breakthroughs bridging lab research with patient care, aiming to enhance outcomes through cutting-edge, research-driven approaches.

About the Speaker:

Professor Zhiqiang Meng, M.D., Ph.D., is a distinguished medical leader in Shanghai’s healthcare landscape, known for his expertise in integrative medicine, oncology, and minimally invasive therapy. Currently, he serves as the Director of the Department of Integrative Oncology and the Minimally Invasive Therapy Center at Fudan University Shanghai Cancer Center. With over 210 published papers and more than 7600 citations, Professor Meng has made significant contributions to medical science. He has led over 70 multi-national clinical studies and secured substantial funding for research. His work focuses on advancing the treatment of liver and pancreatic tumors through innovative integrative and minimally invasive therapies. He is an Adjunct Professor at the M.D. Anderson Cancer Center.